Literature DB >> 11241234

The role of psychosocial factors in the development of breast carcinoma: Part I. The cancer prone personality.

M A Price1, C C Tennant, R C Smith, P N Butow, S J Kennedy, M B Kossoff, S M Dunn.   

Abstract

BACKGROUND: The authors conducted the current study to determine whether personality predisposes some individuals to develop cancer.
METHODS: The current study examined the role of personality variables in 2224 older women recalled for assessment after routine mammography in a breast screening program. Using a semiprospective design, subjects completed self-report measures of defense style, locus of control, emotional expression and control, self-esteem, trait anxiety, and state anxiety and depression while waiting for medical examination. Multivariate analysis of variance was used to control for known risk factor variables and to examine differences between 3 control groups (normal tissue controls, benign/cystic controls not requiring biopsy, and benign biopsy controls) and 298 breast carcinoma subjects.
RESULTS: No differences were detected between breast carcinoma subjects and controls based on measures of mature, immature, and neurotic defense style; locus of control of behavior; emotional expression-in, emotional expression-out, and emotional control; self-esteem; anxiety; or depression.
CONCLUSIONS: The results of the current study found no evidence to support an independent association between these personality measures and the development of breast carcinoma. [See accompanying article on pages 686-97, this issue.] Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11241234

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Mechanisms linking early life stress to adult health outcomes.

Authors:  Shelley E Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-04       Impact factor: 11.205

Review 2.  Neuroendocrine influences on cancer progression.

Authors:  Guillermo N Armaiz-Pena; Steve W Cole; Susan K Lutgendorf; Anil K Sood
Journal:  Brain Behav Immun       Date:  2012-06-21       Impact factor: 7.217

Review 3.  Stress, inflammation, and eicosanoids: an emerging perspective.

Authors:  Sujanitha Umamaheswaran; Santosh K Dasari; Peiying Yang; Susan K Lutgendorf; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

4.  Isoprenaline induces epithelial-mesenchymal transition in gastric cancer cells.

Authors:  Yan-Jie Lu; Zhi-Jun Geng; Xiao-Yan Sun; Yu-Hong Li; Xiao-Bing Fu; Xiang-Yang Zhao; Bo Wei
Journal:  Mol Cell Biochem       Date:  2015-08-08       Impact factor: 3.396

Review 5.  The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.

Authors:  Michael H Antoni; Susan K Lutgendorf; Steven W Cole; Firdaus S Dhabhar; Sandra E Sephton; Paige Green McDonald; Michael Stefanek; Anil K Sood
Journal:  Nat Rev Cancer       Date:  2006-03       Impact factor: 60.716

Review 6.  Neuroendocrine modulation of cancer progression.

Authors:  Guillermo N Armaiz-Pena; Susan K Lutgendorf; Steve W Cole; Anil K Sood
Journal:  Brain Behav Immun       Date:  2008-06-27       Impact factor: 7.217

7.  High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.

Authors:  Firdaus S Dhabhar; Alison N Saul; Tyson H Holmes; Christine Daugherty; Eric Neri; Jean M Tillie; Donna Kusewitt; Tatiana M Oberyszyn
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

8.  Isoprenaline/β2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.

Authors:  Yanjie Lu; Qian Xu; Yanzhen Zuo; Lei Liu; Shaochen Liu; Lei Chen; Kang Wang; Yuntao Lei; Xiangyang Zhao; Yuhong Li
Journal:  BMC Cancer       Date:  2017-12-20       Impact factor: 4.430

9.  The Association between Adverse Events in the Last 5 Years and the Rate of Breast Cancer.

Authors:  Babak Rastegarimehr; Atefeh Zahedi; Parvin Yavari; Mohammad Hassan Lotfi; Moslem Taheri Soodejani
Journal:  Iran J Public Health       Date:  2018-02       Impact factor: 1.429

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.